Nancy Duitch - 21 May 2021 Form 4 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)

Role: Chief Strategy Officer
Signature: /s/ Nancy Duitch
Issuer symbol: AVRW
Transactions as of: 21 May 2021
Transactions value $: $3,675
Form type: 4
Filing time: 24 May 2021, 08:47:47 UTC
Next filing: 27 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVRW	Common Stock	Purchase	$3,675	+5,000	+0.1%	$0.735^*	5,019,869	21 May 2021	By the Duitch Living Trust dated January 9, 1989	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.7100 to $0.7711. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 3 decimal points.

Content

This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.7100 to $0.7711. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 3 decimal points.